Agenda
BioCapital Europe – March 9th 2023
Event organized by
Keynote Sessions
09:00 – Opening Remarks from Rene Kuijten
09:10 – Sam Fazeli, Head of EMEA Research, Bloomberg Intelligence
13:30 – Jeffrey Cummings, Research Professor, Department of Brain Health
13:50 – Q&A Session with Jeffrey Cummings and Philip Scheltens, Head Dementia Fund, EQT
Private BioTech
09:40 – Aviado Bio
10:00 – Egle Therapeutics
10:20 – Cardior
10:40 – Coffee Break
11:00 – Amolyt Pharma
11:20 – Vico Therapeutics
11:40 -Nouscom
12:00 – Ariceum Therapeutics
12:20 – Lunch Break
13:30 – Keynote from Jeffrey Cummings
13:50 – Q&A Session with Jeffrey Cummings and Prof. Dr Philip Scheltens
14:20 – Aelin Therapeutics
14:40 – ImCheck
15:00 – T-knife
15:20 – VarmX
15:40 – Coffee Break
16:00 – Imcyse
16:20 – FoRx Therapeutics
16:40 – SNIPR Biome
17:00 – eTheRNA
Listed Healthcare
09:40 – Vivoryon
10:00 – BioArctic
10:20 – AC Immune
10:40 – Coffee Break
11:00 – Pharvaris
11:20 – Calliditas
11:40 – Sequana Medical
12:00 – New Amsterdam Pharma
12:20 – Lunch Break
13:30 – Keynote from Jeffrey Cummings
13:50 – Q&A Session with Jeffrey Cummings and Prof. Dr Philip Scheltens
14:20 – Oculis
14:40 – Achillies Therapeutics
15:00 – Oryzon
15:20 – Immunic
15:40 – Coffee Break
16:00 – Onwd
16:20 – Binx Health
16:40 – Galapagos
Private MedTech
09:40 – iStar Medical
10:00 – Perfuze
10:20 – Phagenisis
10:40 – Coffee Break
11:00 – VivaSure
11:20 – Versono
11:40 – ViCentra
12:00 – OneProjects
12:20 – Lunch Break
13:30 – Keynote from Jeffrey Cummings
13:50 – Q&A Session with Jeffrey Cummings and Prof. Dr Philip Scheltens
14:20 – Fundamental VR
14:40 – Lumeon
15:00 – Nobi
15:20 – Leo Cancer Care
15:40 – Coffee Break
16:00 – Xeltis
16:20 – Combinostics
16:40 – Onera Health
17:00 – DNA Script
Agenda Highlights
Dr. Jeffrey L. Cummings
Research Professor, Department of Brain Health, University of Nevada
Jeffrey L. Cummings, MD, ScD, joined the UNLV School of Integrated Health Sciences in 2019 as research professor within the department of brain health. Dr. Cummings is the Joy Chambers-Grundy Professor of Brain Science, an endowed professorship. He is the Director of the Chambers-Grundy Center for Transformative Neuroscience, a center devoted to using the tools of neuroscience and neurologic drug development to transform people’s lives.
Prior to UNLV, Dr. Cummings served as founding director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, and as director of the Mary S. Easton Center for Alzheimer’s Disease Research, and director of the Deane F. Johnson Center for Neurotherapeutics, both at UCLA.
A world-renowned Alzheimer’s researcher and leader of clinical trials, Dr. Cummings has been recognized for his scientific and leadership contributions with the American Geriatrics Society’s Henderson Award (2006), the national Alzheimer’s Association’s Ronald and Nancy Reagan Research Award (2008), and the American Association of Geriatric Psychiatry’s Distinguished Scientist Award (2010).
Sam Fazeli
Head of EMEA Research, Bloomberg Intelligence
Sam Fazeli is a senior analyst and the EMEA head of Bloomberg Intelligence, a dynamic platform for in-depth research available on the Bloomberg Professional service at BI.
Dr. Fazeli specializes in European pharmaceuticals and biotechnology.
Dr. Fazeli has over 20 years of experience conducting equity research as a pharmaceutical analyst, working at firms such as Nomura International and HSBC.
Prior to joining Bloomberg in 2010, Dr. Fazeli worked at Piper Jaffray, Ltd. as a pharmaceutical analyst and head of European research. Before transitioning to investment banking, Dr. Fazeli was a research scientist for seven years.
Dr. Fazeli has been ranked a top analyst by both the U.K. and Pan-European Extel surveys. He received a bachelor’s of science from Cardiff University, and a Ph.D. in pharmacology from the University of London.